Skip to main content
. 2022 May 18;14(10):2486. doi: 10.3390/cancers14102486

Figure 5.

Figure 5

Second and third phosphorylations of gemcitabine by the nucleoside monophosphate kinase and nucleoside diphosphate kinase respectively, rendering the active form: difluoro deoxycytidine.